Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida speciesĽuboš Drgoňa, Rosemary A. Barnes, A. Khachatryan et al.|European Journal of Clinical Microbiology & Infectious Diseases|2013Cited by 130
Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised PatientsRosemary A. Barnes, Johan Maertens, Haran T. Schlamm et al.|Clinical Therapeutics|2015Cited by 27
Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People's Republic of ChinaMao Ny, Claudie Charbonneau, Earnshaw SR et al.|DOAJ (DOAJ: Directory of Open Access Journals)|2016Cited by 3